FibroGen is a biotechnology-based drug discovery company.

FibroGen is focused on the discovery, development, and commercialization of new treatments for fibrosis, anemia, conditions associated with tissue damage or injury, and cancer based on our scientific leadership in tissue fibrosis and HIF biology.

FibroGen also develops and produces recombinant human collagens and gelatins using unique production technology that provides the basis for our proprietary cosmetic dermal filler and biomaterials supply business.

Company Overview
An overview of FibroGen's business, products, clinical programs, research and technology.

Business Strategy
An overview of FibroGen's strategy for corporate growth and achieving profitability.

Leadership
List of FibroGen's Executive Officers and Board of Directors.

Investors
Select listing of FibroGen's top investors.

Strategic Alliances
Information on FibroGen's partnering strategy and alliances.

Careers
Listing of job openings at FibroGen and Human Resources contact information.

Contacts
Listing of location and contact information.

FibroGen Europe Corp
A subsidiary of FibroGen.